Arete Wealth Advisors’s Verastem VSTM Stock Holding History

Arete Wealth Advisors’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,904	Closed	-$9K	–	765
2023 Q1	$9K	Buy	1,904 +300	+19%	+$1.9K	﹤0.01%	650
2022 Q4	$7.75K	Buy	+1,604	New	+$7.88K	﹤0.01%	623

Other funds holding VSTM

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Arete Wealth Advisors's VSTM Position: Q2 2023 in Review

Arete Wealth Advisors sold out of Verastem (VSTM) in Q2 2023, closing a stake of 1,904 shares — an estimated $9K sold.

Arete Wealth Advisors first reported a position in VSTM in Q4 2022 and held it in 2 quarters. The position peaked at $9K in Q1 2023. 61 funds tracked by Wall St. Rank hold VSTM as of Q2 2023.

Arete Wealth Advisors reported no remaining Verastem position as of Q2 2023 after selling out during the quarter.
Arete Wealth Advisors sold 1,904 Verastem shares in Q2 2023, an estimated $9K.
Arete Wealth Advisors first reported a position in Verastem in Q4 2022 and held it in 2 quarters.
Arete Wealth Advisors's Verastem position peaked at $9K in Q1 2023.
61 funds tracked by Wall St. Rank held Verastem as of Q2 2023.

Based on Arete Wealth Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.